LILA ORR: Open Payments
NPI 1841223526 · ENGLEWOOD, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$449 in 18 payments from 5 companies in 2025. Trend: 2023 $473 · 2024 $668 · 2025 $449
Food & beverage: $449
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $301 |
| Galderma Laboratories, L.P. | 2 | $49 |
| PFIZER INC. | 3 | $46 |
| UCB, Inc. | 1 | $29 |
| GENZYME CORPORATION | 1 | $24 |
Products named: RINVOQ, SKYRIZI, DYSPORT, CIBINQO, BOTOX, Bimzelx, DUPIXENT.
Industry payments across CO — which companies pay providers there.
